View source for National Institutes of Health Clinical Trials Grants

{{Program
|ProgramName=National Institutes of Health Clinical Trials Grants
|ProgramType=Program
|OrgSponsor=National Institutes of Health
|TopOrganization=Department of Health and Human Services
|CreationLegislation=Public Health Service Act of 1944 (Public Law 78-410), expanded by 21st Century Cures Act of 2016 (Public Law 114-255)
|Purpose=NIH Clinical Trials Grants fund investigator-led trials on interventions like drugs and therapies to boost health, ensuring rigorous science nationwide.
|Website=https://grants.nih.gov/policy/clinical-trials.htm
|ProgramStart=1945 (expanded in 2017 for clinical trials policy)
|InitialFunding=$5 million (initial clinical research funding)
|Duration=Ongoing
|Historic=No
}}
The '''National Institutes of Health (NIH) Clinical Trials Grants''', rooted in the Public Health Service Act of 1944 and expanded under the 21st Century Cures Act of 2016, are administered by the National Institutes of Health (NIH) within the Department of Health and Human Services through its institutes and centers (e.g., National Cancer Institute, National Heart, Lung, and Blood Institute) to provide competitive grants to researchers, allocating over $100 billion since inception to support approximately 10,000 clinical trials annually by 2025. Initially supported with $5 million for early clinical research, it has grown to distribute $10 billion in FY 2024 across 10,000 awards, funding trials for diseases like cancer, Alzheimer’s, and COVID-19 at academic and research institutions nationwide.<ref>{{cite web |url=https://grants.nih.gov/policy/clinical-trials.htm |title=NIH Clinical Trials Policy |publisher=National Institutes of Health}}</ref> Despite its impact, challenges like funding competition, regulatory complexity, and participant recruitment persist (web ID: 6), but it remains a cornerstone of NIH’s clinical research efforts.

{{Official URL (simple)|url=https://grants.nih.gov/policy/clinical-trials.htm}}